Starpharma Holdings Limited (OTCMKTS:SPHRY) Short Interest Up 96.4% in June

Starpharma Holdings Limited (OTCMKTS:SPHRY) was the recipient of a significant increase in short interest in the month of June. As of June 30th, there was short interest totalling 5,500 shares, an increase of 96.4% from the June 15th total of 2,800 shares. Based on an average daily volume of 2,200 shares, the days-to-cover ratio is presently 2.5 days.

Starpharma Stock Performance

SPHRY stock remained flat at $0.60 on Friday. The firm has a 50 day simple moving average of $0.70 and a 200 day simple moving average of $0.87. Starpharma has a 52 week low of $0.60 and a 52 week high of $2.81.

Starpharma Company Profile

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.